News articles about Milestone Scientific (NASDAQ:MLSS) have trended positive recently, Accern Sentiment reports. Accern identifies positive and negative press coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Milestone Scientific earned a news impact score of 0.28 on Accern’s scale. Accern also gave news headlines about the company an impact score of 46.1908813602317 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Separately, Maxim Group reiterated a “buy” rating and issued a $4.00 price target on shares of Milestone Scientific in a research note on Tuesday, August 15th.

Shares of Milestone Scientific (MLSS) traded up 4.00% during mid-day trading on Friday, reaching $1.30. The company’s stock had a trading volume of 28,283 shares. The stock’s market capitalization is $42.89 million. Milestone Scientific has a 12 month low of $1.08 and a 12 month high of $2.67. The company has a 50 day moving average price of $1.30 and a 200 day moving average price of $1.39.

COPYRIGHT VIOLATION WARNING: This news story was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this news story on another website, it was illegally copied and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this news story can be accessed at https://www.thecerbatgem.com/2017/08/26/favorable-press-coverage-somewhat-unlikely-to-impact-milestone-scientific-mlss-stock-price.html.

Milestone Scientific Company Profile

Milestone Scientific Inc (Milestone) is engaged in providing computer-controlled injection technologies and solutions for the medical and dental markets. The Company uses its CompuFlo technology for the delivery of medicaments. The CompuFlo pressure or force Computer-Controlled Local Anesthetic Delivery (C-CLAD) technology is a medical technology for the delivery of drugs, anesthetics and other medicaments into various tissue types.

Insider Buying and Selling by Quarter for Milestone Scientific (NASDAQ:MLSS)

Receive News & Stock Ratings for Milestone Scientific Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific Inc. and related stocks with our FREE daily email newsletter.